Anti-thymocyte globulin (ATG)
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Anti-thymocyte globulin (ATG), covering 2009-07-08 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes [Phase 1, Phase 2]